{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:56:42Z","timestamp":1794445002758,"version":"4.9.1"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eClinicalMedicine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.eclinm.2024.102749","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T20:56:56Z","timestamp":1722027416000},"page":"102749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Approach to diagnosing and managing granulomatous-lymphocytic interstitial lung disease"],"prefix":"10.1016","volume":"75","author":[{"given":"Jessica","family":"Galant-Swafford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2630-8882","authenticated-orcid":false,"given":"Jason","family":"Catanzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosane Duarte","family":"Achcar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlyne","family":"Cool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tilman","family":"Koelsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tami J.","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafeul","family":"Alam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit K.","family":"Katial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7535-1591","authenticated-orcid":false,"given":"Evans R.","family":"Fern\u00e1ndez P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.eclinm.2024.102749_bib1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/1744666X.2020.1801422","article-title":"Global systematic review of primary immunodeficiency registries","volume":"16","author":"Abolhassani","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102749_bib2","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1067\/mai.2002.124999","article-title":"Efficacy of intravenous immunoglobulin in the prevention of pneumonia in patients with common variable immunodeficiency","volume":"109","author":"Busse","year":"2002","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102749_bib3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s13023-018-0941-0","article-title":"The burden of common variable immunodeficiency disorders: a retrospective analysis of the European Society for Immunodeficiency (ESID) registry data","volume":"13","author":"Odnoletkova","year":"2018","journal-title":"Orphanet J Rare Dis"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102749_bib4","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.jaip.2018.09.030","article-title":"United States trends in mortality rates for primary immunodeficiency diseases","volume":"7","author":"Fernandez Perez","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102749_bib5","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1182\/blood-2011-09-377945","article-title":"Morbidity and mortality in common variable immune deficiency over 4 decades","volume":"119","author":"Resnick","year":"2012","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102749_bib6","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.jaci.2004.05.057","article-title":"Granulomatous-lymphocytic lung disease shortens survival in common variable immunodeficiency","volume":"114","author":"Bates","year":"2004","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.eclinm.2024.102749_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.1033666","article-title":"Current clinical spectrum of common variable immunodeficiency in Spain: the multicentric nationwide GTEM-SEMI-CVID registry","volume":"13","author":"Cabanero-Navalon","year":"2022","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102749_bib8","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.jaip.2017.01.021","article-title":"British lung foundation\/United Kingdom primary immunodeficiency Network consensus statement on the definition, diagnosis, and management of granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency disorders","volume":"5","author":"Hurst","year":"2017","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102749_bib9","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1007\/s10875-018-0554-3","article-title":"Novel STAT1 gain-of-function mutation presenting as combined immunodeficiency","volume":"38","author":"Hartono","year":"2018","journal-title":"J\u00a0Clin Immunol"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102749_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/s11882-018-0769-7","article-title":"Granulomatous-lymphocytic interstitial lung disease in 22q11.2 deletion syndrome: a case report and literature review","volume":"18","author":"Sood","year":"2018","journal-title":"Curr Allergy Asthma Rep"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102749_bib11","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/cei.12178","article-title":"New diagnostic criteria for common variable immune deficiency (CVID), which may assist with decisions to treat with intravenous or subcutaneous immunoglobulin","volume":"174","author":"Ameratunga","year":"2013","journal-title":"Clin Exp Immunol"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102749_bib12","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1016\/j.jaip.2019.02.004","article-title":"The European society for immunodeficiencies (ESID) registry working definitions for the clinical diagnosis of inborn errors of immunity","volume":"7","author":"Seidel","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102749_bib13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jaip.2015.07.025","article-title":"International consensus document (ICON): common variable immunodeficiency disorders","volume":"4","author":"Bonilla","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102749_bib14","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1513\/AnnalsATS.201511-728OC","article-title":"Clinical predictors of a diagnosis of common variable immunodeficiency-related granulomatous-lymphocytic interstitial lung disease","volume":"13","author":"Mannina","year":"2016","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/j.eclinm.2024.102749_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.627423","article-title":"Granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID): a multicenter retrospective study of patients from Italian PID referral centers","volume":"12","author":"Cinetto","year":"2021","journal-title":"Front Immunol"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102749_bib16","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.clim.2008.02.013","article-title":"Memory B cells in common variable immunodeficiency: clinical associations and sex differences","volume":"128","author":"Sanchez-Ramon","year":"2008","journal-title":"Clin Immunol"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102749_bib17","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.jaci.2020.07.021","article-title":"Rituximab and antimetabolite treatment of granulomatous and lymphocytic interstitial lung disease in common variable immunodeficiency","volume":"147","author":"Verbsky","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102749_bib18","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1016\/j.jaip.2019.02.038","article-title":"Outcomes and treatment strategies for autoimmunity and hyperinflammation in patients with RAG deficiency","volume":"7","author":"Farmer","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"6246","key":"10.1016\/j.eclinm.2024.102749_bib19","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1126\/science.aaa1663","article-title":"Autoimmune disease. Patients with LRBA deficiency show CTLA4 loss and immune dysregulation responsive to abatacept therapy","volume":"349","author":"Lo","year":"2015","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102749_bib20","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1016\/j.jaci.2018.01.039","article-title":"Loss-of-function nuclear factor kappaB subunit 1 (NFKB1) variants are the most common monogenic cause of common variable immunodeficiency in Europeans","volume":"142","author":"Tuijnenburg","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102749_bib21","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s10875-022-01318-1","article-title":"Raised serum markers of T cell activation and exhaustion in granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency","volume":"42","author":"Fraz","year":"2022","journal-title":"J\u00a0Clin Immunol"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102749_bib22","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122728","article-title":"BAFF-driven B cell hyperplasia underlies lung disease in common variable immunodeficiency","volume":"4","author":"Maglione","year":"2019","journal-title":"JCI Insight"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102749_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0074893","article-title":"Interferon signature in the blood in inflammatory common variable immune deficiency","volume":"8","author":"Park","year":"2013","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102749_bib24","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/s10875-014-0052-1","article-title":"Ill-defined germinal centers and severely reduced plasma cells are histological hallmarks of lymphadenopathy in patients with common variable immunodeficiency","volume":"34","author":"Unger","year":"2014","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.eclinm.2024.102749_bib25","article-title":"Bronchoalveolar lavage fluid reflects a T(H)1-CD21(low) B-cell interaction in CVID-related interstitial lung disease","volume":"11","author":"Friedmann","year":"2020","journal-title":"Front Immunol"},{"issue":"32","key":"10.1016\/j.eclinm.2024.102749_bib26","doi-asserted-by":"crossref","first-page":"13451","DOI":"10.1073\/pnas.0901984106","article-title":"Circulating CD21low B cells in common variable immunodeficiency resemble tissue homing, innate-like B cells","volume":"106","author":"Rakhmanov","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102749_bib27","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s10875-023-01485-9","article-title":"Dysregulated lymphocyte antigen receptor signaling in common variable immunodeficiency with granulomatous lymphocytic interstitial lung disease","volume":"43","author":"Lui","year":"2023","journal-title":"J\u00a0Clin Immunol"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102749_bib28","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1111\/imr.12821","article-title":"Impaired B-cell tolerance checkpoints promote the development of autoimmune diseases and pathogenic autoantibodies","volume":"292","author":"Meffre","year":"2019","journal-title":"Immunol Rev"},{"issue":"10","key":"10.1016\/j.eclinm.2024.102749_bib29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","article-title":"ERK signalling: a master regulator of cell behaviour, life and fate","volume":"21","author":"Lavoie","year":"2020","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"9","key":"10.1016\/j.eclinm.2024.102749_bib30","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.humpath.2015.05.011","article-title":"Granulomatous and lymphocytic interstitial lung disease: a spectrum of pulmonary histopathologic lesions in common variable immunodeficiency--histologic and immunohistochemical analyses of 16 cases","volume":"46","author":"Rao","year":"2015","journal-title":"Hum Pathol"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102749_bib31","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/ppul.24599","article-title":"Bronchiectasis in common variable immunodeficiency: a systematic review and meta-analysis","volume":"55","author":"Ramzi","year":"2020","journal-title":"Pediatr Pulmonol"},{"issue":"Suppl 1","key":"10.1016\/j.eclinm.2024.102749_bib32","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/thoraxjnl-2018-212463","article-title":"British thoracic society guideline for bronchiectasis in adults","volume":"74","author":"Hill","year":"2019","journal-title":"Thorax"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102749_bib33","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1007\/s10875-023-01552-1","article-title":"Common and uncommon CT findings in CVID-related GL-ILD: correlations with clinical parameters, therapeutic decisions and potential implications in the differential diagnosis","volume":"43","author":"Scarpa","year":"2023","journal-title":"J\u00a0Clin Immunol"},{"key":"10.1016\/j.eclinm.2024.102749_bib34","article-title":"Granulomatous-lymphocytic interstitial lung disease in common variable immunodeficiency-features of CT and (18)F-FDG positron emission tomography\/CT in clinically progressive disease","volume":"11","author":"Fraz","year":"2020","journal-title":"Front Immunol"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102749_bib35","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/RTI.0000000000000350","article-title":"Pulmonary manifestations of common variable immunodeficiency","volume":"33","author":"Bang","year":"2018","journal-title":"J\u00a0Thorac Imaging"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102749_bib36","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.iac.2012.08.003","article-title":"Granulomatous lymphocytic interstitial lung disease","volume":"32","author":"Fernandez Perez","year":"2012","journal-title":"Immunol Allergy Clin North Am"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102749_bib37","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/RTI.0b013e318166d32f","article-title":"Granulomatous-lymphocytic interstitial lung disease associated with common variable immunodeficiency: CT findings","volume":"23","author":"Torigian","year":"2008","journal-title":"J\u00a0Thorac Imaging"},{"issue":"7","key":"10.1016\/j.eclinm.2024.102749_bib38","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1177\/34.7.3754881","article-title":"Cellular heterogeneity in normal human urothelium: an analysis of optical properties and lectin binding","volume":"34","author":"Ward","year":"1986","journal-title":"J\u00a0Histochem Cytochem"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102749_bib39","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1183\/09031936.00025212","article-title":"Imaging of sarcoidosis of the airways and lung parenchyma and correlation with lung function","volume":"40","author":"Nunes","year":"2012","journal-title":"Eur Respir J"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102749_bib40","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s10875-020-00769-8","article-title":"Lymphoproliferative disease in CVID: a report of types and frequencies from a US patient registry","volume":"40","author":"Yakaboski","year":"2020","journal-title":"J\u00a0Clin Immunol"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102749_bib41","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1159\/000050475","article-title":"Pulmonary mucosa-associated lymphoid tissue lymphoma in a patient with common variable immunodeficiency syndrome","volume":"68","author":"Reichenberger","year":"2001","journal-title":"Respiration"},{"key":"10.1016\/j.eclinm.2024.102749_bib42","doi-asserted-by":"crossref","first-page":"149","DOI":"10.3389\/fimmu.2020.00149","article-title":"Non-infectious complications of common variable immunodeficiency: updated clinical spectrum, sequelae, and insights to pathogenesis","volume":"11","author":"Ho","year":"2020","journal-title":"Front Immunol"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102749_bib43","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/PAS.0000000000001479","article-title":"GLILD revisited: pulmonary pathology of common variable and selective IgA immunodeficiency","volume":"44","author":"Larsen","year":"2020","journal-title":"Am J Surg Pathol"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102749_bib44","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1016\/j.jaci.2010.02.040","article-title":"Infection outcomes in patients with common variable immunodeficiency disorders: relationship to immunoglobulin therapy over 22 years","volume":"125","author":"Lucas","year":"2010","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4 Suppl","key":"10.1016\/j.eclinm.2024.102749_bib45","doi-asserted-by":"crossref","first-page":"S525","DOI":"10.1016\/j.jaci.2006.01.015","article-title":"Use of intravenous immunoglobulin in human disease: a review of evidence by members of the primary immunodeficiency committee of the American academy of allergy, asthma and immunology","volume":"117","author":"Orange","year":"2006","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102749_bib46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.clim.2010.06.012","article-title":"Impact of trough IgG on pneumonia incidence in primary immunodeficiency: a meta-analysis of clinical studies","volume":"137","author":"Orange","year":"2010","journal-title":"Clin Immunol"},{"issue":"8541","key":"10.1016\/j.eclinm.2024.102749_bib47","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/S0140-6736(87)90494-6","article-title":"High-dose versus low-dose intravenous immunoglobulin in hypogammaglobulinaemia and chronic lung disease","volume":"1","author":"Roifman","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.eclinm.2024.102749_bib48","article-title":"Organising pneumonia in common variable immunodeficiency","volume":"2013","author":"Boujaoude","year":"2013","journal-title":"BMJ Case Rep"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102749_bib49","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1159\/000029552","article-title":"Organizing pneumonia related to common variable immunodeficiency. case report and literature review","volume":"67","author":"Wislez","year":"2000","journal-title":"Respiration"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102749_bib50","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/00007611-200093060-00023","article-title":"Noncaseating granulomatous disease in common variable immunodeficiency","volume":"93","author":"Kanathur","year":"2000","journal-title":"South Med J"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102749_bib51","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1378\/chest.100.2.552","article-title":"Bronchiolitis obliterans organizing pneumonia in common variable immunodeficiency syndrome","volume":"100","author":"Kaufman","year":"1991","journal-title":"Chest"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102749_bib52","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/0091-6749(82)90066-5","article-title":"Common variable hypogammaglobulinemia with T-cell nodular lymphoid interstitial pneumonitis and B-cell nodular lymphoid hyperplasia: different lymphocyte populations with a similar response to prednisone therapy","volume":"70","author":"Kohler","year":"1982","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102749_bib53","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.jaci.2022.12.813","article-title":"The efficacy and safety of systemic corticosteroids as first line treatment for granulomatous lymphocytic interstitial lung disease","volume":"152","author":"Smits","year":"2023","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102749_bib54","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/crj.12511","article-title":"Granulomatous-lymphocytic interstitial lung disease as the first manifestation of common variable immunodeficiency","volume":"12","author":"Tashtoush","year":"2018","journal-title":"Clin Respir J"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102749_bib55","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1007\/s10875-023-01587-4","article-title":"Rituximab monotherapy is effective as first-line treatment for granulomatous lymphocytic interstitial lung disease (GLILD) in CVID patients","volume":"43","author":"Tessarin","year":"2023","journal-title":"J\u00a0Clin Immunol"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102749_bib56","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.jaip.2021.10.040","article-title":"Rituximab as a single agent for successful treatment of granulomatous and lymphocytic interstitial lung disease in a pediatric patient with common variable immunodeficiency","volume":"10","author":"Kosinski","year":"2022","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102749_bib57","doi-asserted-by":"crossref","first-page":"e117","DOI":"10.1016\/j.chest.2019.01.034","article-title":"Rituximab monotherapy for common variable immune deficiency-associated granulomatous-lymphocytic interstitial lung disease","volume":"155","author":"Ng","year":"2019","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.eclinm.2024.102749_bib58","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.jaip.2018.10.041","article-title":"Efficacy of rituximab as a single-agent therapy for the treatment of granulomatous and lymphocytic interstitial lung disease in patients with common variable immunodeficiency","volume":"7","author":"Cereser","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102749_bib59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.pcl.2016.08.007","article-title":"Immunodeficiency presenting as an undiagnosed disease","volume":"64","author":"Routes","year":"2017","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/j.eclinm.2024.102749_bib60","article-title":"Management of granulomatous lymphocytic interstitial lung disease in a patient with common variable immune deficiency","volume":"2016","author":"Pathria","year":"2016","journal-title":"BMJ Case Rep"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102749_bib61","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s10875-012-9755-3","article-title":"Use of combination chemotherapy for treatment of granulomatous and lymphocytic interstitial lung disease (GLILD) in patients with common variable immunodeficiency (CVID)","volume":"33","author":"Chase","year":"2013","journal-title":"J\u00a0Clin Immunol"},{"issue":"10","key":"10.1016\/j.eclinm.2024.102749_bib62","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.1002\/ppul.23757","article-title":"Efficacy of mycophenolate on lung disease and autoimmunity in children with immunodeficiency","volume":"52","author":"Bucciol","year":"2017","journal-title":"Pediatr Pulmonol"},{"issue":"1","key":"10.1016\/j.eclinm.2024.102749_bib63","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/cei.12856","article-title":"FDG PET-CT imaging of therapeutic response in granulomatous lymphocytic interstitial lung disease (GLILD) in common variable immunodeficiency (CVID)","volume":"187","author":"Jolles","year":"2017","journal-title":"Clin Exp Immunol"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102749_bib64","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1016\/j.jaip.2019.06.011","article-title":"Abatacept as a long-term targeted therapy for LRBA deficiency","volume":"7","author":"Kiykim","year":"2019","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102749_bib65","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1182\/blood.2021013496","article-title":"Abatacept is useful in autoimmune cytopenia with immunopathologic manifestations caused by CTLA-4 defects","volume":"139","author":"Dhunputh","year":"2022","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.eclinm.2024.102749_bib66","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s10875-017-0446-y","article-title":"Multiple presentations of LRBA deficiency: a single-center experience","volume":"37","author":"Kostel","year":"2017","journal-title":"J\u00a0Clin Immunol"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102749_bib67","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.jaci.2018.02.055","article-title":"Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects","volume":"142","author":"Schwab","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.eclinm.2024.102749_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.704261","article-title":"Rituximab and abatacept are effective in differential treatment of interstitial lymphocytic lung disease in children with primary immunodeficiencies","volume":"12","author":"Rodina","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102749_bib69","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jaip.2020.10.028","article-title":"Abatacept use is associated with steroid dose reduction and improvement in fatigue and CD4-dysregulation in CVID patients with interstitial lung disease","volume":"9","author":"von Spee-Mayer","year":"2021","journal-title":"J\u00a0Allergy Clin Immunol Pract"},{"key":"10.1016\/j.eclinm.2024.102749_bib70","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.606099","article-title":"Treatment strategies for GLILD in common variable immunodeficiency: a systematic review","volume":"12","author":"Lamers","year":"2021","journal-title":"Front Immunol"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102749_bib71","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1080\/1744666X.2018.1459189","article-title":"Clinical considerations in the hematopoietic stem cell transplant management of primary immunodeficiencies","volume":"14","author":"Laberko","year":"2018","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102749_bib72","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.jaci.2016.01.045","article-title":"Hematopoietic stem cell transplantation for CTLA4 deficiency","volume":"138","author":"Slatter","year":"2016","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.eclinm.2024.102749_bib73","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jaci.2011.07.055","article-title":"Outcome of allogeneic stem cell transplantation in adults with common variable immunodeficiency","volume":"128","author":"Rizzi","year":"2011","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"5","key":"10.1016\/j.eclinm.2024.102749_bib74","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.jaci.2019.12.896","article-title":"Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score","volume":"145","author":"Tesch","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.eclinm.2024.102749_bib75","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.jaci.2014.11.029","article-title":"Multicenter experience in hematopoietic stem cell transplantation for serious complications of common variable immunodeficiency","volume":"135","author":"Wehr","year":"2015","journal-title":"J\u00a0Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.eclinm.2024.102749_bib76","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jaci.2017.04.023","article-title":"Treatment of severe forms of LPS-responsive beige-like anchor protein deficiency with allogeneic hematopoietic stem cell transplantation","volume":"141","author":"Seidel","year":"2018","journal-title":"J\u00a0Allergy Clin Immunol"}],"container-title":["eClinicalMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024003286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589537024003286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T13:46:28Z","timestamp":1728395188000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589537024003286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":76,"alternative-id":["S2589537024003286"],"URL":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102749","relation":{},"ISSN":["2589-5370"],"issn-type":[{"value":"2589-5370","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Approach to diagnosing and managing granulomatous-lymphocytic interstitial lung disease","name":"articletitle","label":"Article Title"},{"value":"eClinicalMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eclinm.2024.102749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"102749"}}